C-Reactive Protein and Procalcitonin as Markers for Post-Bronchoscopic Complications: A Literature Review
DOI:
https://doi.org/10.36497/jri.v44i2.638Keywords:
bronchoscopy, CRP, marker, PCTAbstract
In the respiratory system, bronchoscopy is a basic procedure utilized for both diagnostic and therapeutic purposes. Despite being a generally safe procedure, bronchoscopy can result in complications that range in severity from moderate to severe. Pulmonary infection is among the potential complications that can happen after a bronchoscopy procedure. An incidence of 0.2% to 5.2% has been described typically for complications such as empyema, lung abscess, and pneumonia that may develop after bronchoscopy procedures. Although these complications are uncommon, their prognosis can be quite bad. The risk of pulmonary infection, specifically pneumonia, has been related in several studies to sepsis and mortality in patients enduring bronchoscopy procedures. The initiation of the infection exposure process into the lung can be assisted through a variety of factors, including the underlying diagnosis and the type of intervention performed during the bronchoscopy procedure. A critical complication that needs additional consideration is the potential transmission of infection through bronchoscopy procedures. It is beneficial to consider prophylactic antibiotics before a procedure due to the possibility that infectious agents will be transferred from one patient to another. Antibiotic prophylaxis may involve the utilization of C-reactive protein (CRP) and Procalcitonin (PCT) testing as determining parameters. Serial PCT and CRP 24–96 hours post-bronchoscopy procedure might help to determine one of the post-bronchoscopy complications.
Downloads
References
Perhimpunan Dokter Paru Indonesia. Buku ajar pulmonologi dan kedokteran respirasi. 1st ed. Rasmin M, Jusuf A, Amin M, Taufik, Nawas MA, Ngurah Rai IB, et al., editors. Jakarta: UI Press; 2017. 401–420 p.
Lim JH, Kim MJ, Jeon SH, Park MH, Kim WY, Lee M, et al. The optimal sequence of bronchial brushing and washing for diagnosing peripheral lung cancer using non-guided flexible bronchoscopy. Scientific Reports 2020 10:1. 2020;10(1):1–7.
Hackner K, Riegler W, Handzhiev S, Bauer R, Veres J, Speiser M, et al. Fever after bronchoscopy: Serum procalcitonin enables early diagnosis of post-interventional bacterial infection. BMC Pulm Med. 2017;17(1):156.
Farrokhpour M, Kiani A, Mortaz E, Taghavi K, Farahbod AM, Fakharian A, et al. Procalcitonin and proinflammatory cytokines in early diagnosis of bacterial infections after bronchoscopy. Open Access Maced J Med Sci. 2019;7(6):913–9.
Díaz-Jimenez, Pablo J, Rodriguez, N A. Interventions in pulmonary medicine. 2nd ed. Springer; 2017.
Wang S, Tu J, Shui Y, Zhao S. The predictive value of C-reactive protein for endobronchial, biopsy-induced bleeding in patients with lung cancer. Int J Clin Exp Med. 2019;12(4):4154–60.
Aguñín PR. Infectious complications following bronchoscopy: Does sedation play a role? J Lung Pulm Respir Res. 2018;5(4):112–8.
Sato Y, Murata K, Yamamoto M, Ishiwata T, Kitazono-Saitoh M, Wada A, et al. Risk factors for post-bronchoscopy pneumonia: a case-control study. Sci Rep. 2020;10(1):19983.
Takiguchi H, Hayama N, Oguma T, Harada K, Sato M, Horio Y, et al. Post-bronchoscopy pneumonia in patients suffering from lung cancer: Development and validation of a risk prediction score. Respir Investig. 2017;55(3):212–8.
Shimizu T, Okachi S, Imai N, Hase T, Morise M, Hashimoto N, et al. Risk factors for pulmonary infection after diagnostic bronchoscopy in patients with lung cancer. Nagoya J Med Sci. 2020;82(1):69–77.
Nehring SM, Goyal A, Bansal P, Patel BC. C reactive protein. StatPearls. 2023;65(5):237–44.
Sproston NR, Ashworth JJ. Role of c-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9(APR):754.
Coster D, Wasserman A, Fisher E, Rogowski O, Zeltser D, Shapira I, et al. Using the kinetics of c-reactive protein response to improve the differential diagnosis between acute bacterial and viral infections. Infection. 2020;48(2):241–8.
Bernstein D, Coster D, Berliner S, Shapira I, Zeltser D, Rogowski O, et al. C-reactive protein velocity discriminates between acute viral and bacterial infections in patients who present with relatively low CRP concentrations. BMC Infect Dis. 2021;21(1):1210.
McFadyen JD, Kiefer J, Braig D, Loseff-Silver J, Potempa LA, Eisenhardt SU, et al. Dissociation of c-reactive protein localizes and amplifies inflammation: Evidence for a direct biological role of c-reactive protein and its conformational changes. Front Immunol. 2018;9:1351.
Creamer AW, Kent AE, Albur M. Procalcitonin in respiratory disease: Use as a biomarker for diagnosis and guiding antibiotic therapy. Breathe (Sheff). 2019;15(4):296–304.
Bai Y, Lu J, Cheng Y, Zhang F, Fan X, Weng Y, et al. NF-кB increases LPS-mediated procalcitonin production in human hepatocytes. Scientific Reports 2018 8:1. 2018;8(1):1–9.
Memar MY, Varshochi M, Shokouhi B, Asgharzadeh M, Kafil HS. Procalcitonin: The marker of pediatric bacterial infection. Biomed Pharmacother. 2017;96:936–43.
Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: A patient level meta-analysis. Lancet Infect Dis. 2018;18(1):95–107.
Yeh CF, Wu CC, Liu SH, Chen KF. Comparison of the accuracy of neutrophil CD64, procalcitonin, and C-reactive protein for sepsis identification: A systematic review and meta-analysis. Ann Intensive Care. 2019;9(1):5.
Zandstra J, Jongerius I, Kuijpers TW. Future biomarkers for infection and inflammation in febrile children. Front Immunol. 2021;12:631308.
Koizumi Y, Sakanashi D, Ohno T, Nakamura A, Yamada A, Shibata Y, et al. Plasma procalcitonin levels remain low at the onset of gram-positive bacteremia regardless of severity or the presence of shock: A retrospective analysis of patients with detailed clinical characteristics. J Microbiol Immunol Infect. 2021;54(6):1028–37.
Bassetti M, Russo A, Righi E, Dolso E, Merelli M, D’Aurizio F, et al. Role of procalcitonin in predicting etiology in bacteremic patients: Report from a large single-center experience. J Infect Public Health. 2020;13(1):40–5.
Lee EH, Lee KH, Song YG, Han SH. Discrepancy of c-reactive protein, procalcitonin and interleukin-6 at hospitalization: Infection in patients with normal c-reactive protein, procalcitonin and high interleukin-6 values. J Clin Med. 2022;11(24):7324.
Tan M, Lu Y, Jiang H, Zhang L. The diagnostic accuracy of procalcitonin and c-reactive protein for sepsis: A systematic review and meta-analysis. J Cell Biochem. 2019;120(4):5852–9.
Kamat IS, Ramachandran V, Eswaran H, Guffey D, Musher DM. Procalcitonin to distinguish viral from bacterial pneumonia: A systematic review and meta-analysis. Clin Infect Dis. 2020;70(3):538–42.
Picard E, Schwartz S, Goldberg S, Glick T, Villa Y, Kerem E. A prospective study of fever and bacteremia after flexible fiberoptic bronchoscopy in children. Chest. 2000;117(2):573–7.
Díaz-Jimenez JP, Rodriguez AN. Rigid bronchoscopy. Interventions in Pulmonary Medicine [Internet]. 2017 Jan 1 [cited 2023 Nov 4];47–66. Available from: https://link.springer.com/chapter/10.1007/978-3-319-58036-4_4
Niehues T. C-reactive protein and other biomarkers—the sense and non-sense of using inflammation biomarkers for the diagnosis of severe bacterial infection. 2018;5(2):35–47.
Downloads
Additional Files
Published
Issue
Section
License
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.
